Selected research
Industry Growth & Trends
Global Drugs for PNH Industry Growth and Trends Forecast to 2032
Market perspective
The global Drugs for PNH market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Drugs for PNH is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Drugs for PNH is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Drugs for PNH is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Drugs for PNH include Alexion Pharmaceuticals, Amgen, Apellis Pharmaceuticals, Roche, Novartis and Samsung Bioepis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Drugs for PNH market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Drugs for PNH market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drugs for PNH market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drugs for PNH.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Drugs for PNH market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Drugs for PNH Market by Company
Alexion Pharmaceuticals
Amgen
Apellis Pharmaceuticals
Roche
Novartis
Samsung Bioepis
Drugs for PNH Segment by Type
Complement Inhibitors
Others
Drugs for PNH Segment by Application
Hospital
Clinic
Other
Drugs for PNH Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for PNH market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs for PNH and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for PNH.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs for PNH manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Drugs for PNH in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Complement Inhibitors
- Others
Applications
- Hospital
- Clinic
- Other
Companies covered
- Alexion Pharmaceuticals
- Amgen
- Apellis Pharmaceuticals
- Roche
- Novartis
- Samsung Bioepis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Drugs for PNH Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Drugs for PNH Sales Estimates and Forecasts (2021-2032)
- 1.3 Drugs for PNH Market by Type
- 1.3.1 Complement Inhibitors
- 1.3.2 Others
- 1.4 Global Drugs for PNH Market Size by Type
- 1.4.1 Global Drugs for PNH Market Size Overview by Type (2021-2032)
- 1.4.2 Global Drugs for PNH Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Drugs for PNH Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Drugs for PNH Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Drugs for PNH Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Drugs for PNH Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Drugs for PNH Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Drugs for PNH Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Drugs for PNH Industry Trends
- 2.2 Drugs for PNH Industry Drivers
- 2.3 Drugs for PNH Industry Opportunities and Challenges
- 2.4 Drugs for PNH Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Drugs for PNH Revenue (2021-2026)
- 3.2 Global Top Players by Drugs for PNH Sales (2021-2026)
- 3.3 Global Top Players by Drugs for PNH Price (2021-2026)
- 3.4 Global Drugs for PNH Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Drugs for PNH Major Company Production Sites & Headquarters
- 3.6 Global Drugs for PNH Company, Product Type & Application
- 3.7 Global Drugs for PNH Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Drugs for PNH Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Drugs for PNH Players Market Share by Revenue in 2025
- 3.8.3 2025 Drugs for PNH Tier 1, Tier 2, and Tier 3
4 Drugs for PNH Regional Status and Outlook
- 4.1 Global Drugs for PNH Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Drugs for PNH Historic Market Size by Region
- 4.2.1 Global Drugs for PNH Sales in Volume by Region (2021-2026)
- 4.2.2 Global Drugs for PNH Sales in Value by Region (2021-2026)
- 4.2.3 Global Drugs for PNH Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Drugs for PNH Forecasted Market Size by Region
- 4.3.1 Global Drugs for PNH Sales in Volume by Region (2027-2032)
- 4.3.2 Global Drugs for PNH Sales in Value by Region (2027-2032)
- 4.3.3 Global Drugs for PNH Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Drugs for PNH by Application
- 5.1 Drugs for PNH Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Drugs for PNH Market Size by Application
- 5.2.1 Global Drugs for PNH Market Size Overview by Application (2021-2032)
- 5.2.2 Global Drugs for PNH Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Drugs for PNH Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Drugs for PNH Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Drugs for PNH Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Drugs for PNH Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Drugs for PNH Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Drugs for PNH Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Alexion Pharmaceuticals
- 6.1.1 Alexion Pharmaceuticals Company Information
- 6.1.2 Alexion Pharmaceuticals Business Overview
- 6.1.3 Alexion Pharmaceuticals Drugs for PNH Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Alexion Pharmaceuticals Drugs for PNH Product Portfolio
- 6.1.5 Alexion Pharmaceuticals Recent Developments
- 6.2 Amgen
- 6.2.1 Amgen Company Information
- 6.2.2 Amgen Business Overview
- 6.2.3 Amgen Drugs for PNH Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Amgen Drugs for PNH Product Portfolio
- 6.2.5 Amgen Recent Developments
- 6.3 Apellis Pharmaceuticals
- 6.3.1 Apellis Pharmaceuticals Company Information
- 6.3.2 Apellis Pharmaceuticals Business Overview
- 6.3.3 Apellis Pharmaceuticals Drugs for PNH Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Apellis Pharmaceuticals Drugs for PNH Product Portfolio
- 6.3.5 Apellis Pharmaceuticals Recent Developments
- 6.4 Roche
- 6.4.1 Roche Company Information
- 6.4.2 Roche Business Overview
- 6.4.3 Roche Drugs for PNH Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Roche Drugs for PNH Product Portfolio
- 6.4.5 Roche Recent Developments
- 6.5 Novartis
- 6.5.1 Novartis Company Information
- 6.5.2 Novartis Business Overview
- 6.5.3 Novartis Drugs for PNH Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Novartis Drugs for PNH Product Portfolio
- 6.5.5 Novartis Recent Developments
- 6.6 Samsung Bioepis
- 6.6.1 Samsung Bioepis Company Information
- 6.6.2 Samsung Bioepis Business Overview
- 6.6.3 Samsung Bioepis Drugs for PNH Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Samsung Bioepis Drugs for PNH Product Portfolio
- 6.6.5 Samsung Bioepis Recent Developments
7 North America by Country
- 7.1 North America Drugs for PNH Sales by Country
- 7.1.1 North America Drugs for PNH Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Drugs for PNH Sales by Country (2021-2026)
- 7.1.3 North America Drugs for PNH Sales Forecast by Country (2027-2032)
- 7.2 North America Drugs for PNH Market Size by Country
- 7.2.1 North America Drugs for PNH Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Drugs for PNH Market Size by Country (2021-2026)
- 7.2.3 North America Drugs for PNH Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Drugs for PNH Sales by Country
- 8.1.1 Europe Drugs for PNH Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Drugs for PNH Sales by Country (2021-2026)
- 8.1.3 Europe Drugs for PNH Sales Forecast by Country (2027-2032)
- 8.2 Europe Drugs for PNH Market Size by Country
- 8.2.1 Europe Drugs for PNH Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Drugs for PNH Market Size by Country (2021-2026)
- 8.2.3 Europe Drugs for PNH Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Drugs for PNH Sales by Country
- 9.1.1 Asia-Pacific Drugs for PNH Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Drugs for PNH Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Drugs for PNH Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Drugs for PNH Market Size by Country
- 9.2.1 Asia-Pacific Drugs for PNH Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Drugs for PNH Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Drugs for PNH Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Drugs for PNH Sales by Country
- 10.1.1 South America Drugs for PNH Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Drugs for PNH Sales by Country (2021-2026)
- 10.1.3 South America Drugs for PNH Sales Forecast by Country (2027-2032)
- 10.2 South America Drugs for PNH Market Size by Country
- 10.2.1 South America Drugs for PNH Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Drugs for PNH Market Size by Country (2021-2026)
- 10.2.3 South America Drugs for PNH Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Drugs for PNH Sales by Country
- 11.1.1 Middle East and Africa Drugs for PNH Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Drugs for PNH Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Drugs for PNH Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Drugs for PNH Market Size by Country
- 11.2.1 Middle East and Africa Drugs for PNH Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Drugs for PNH Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Drugs for PNH Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Drugs for PNH Value Chain Analysis
- 12.1.1 Drugs for PNH Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Drugs for PNH Production Mode & Process
- 12.2 Drugs for PNH Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Drugs for PNH Distributors
- 12.2.3 Drugs for PNH Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst